on-invasive treatment of urinary symptoms and quality of life in women with Multiple Sclerosis
- Conditions
- Multiple SclerosisC10.114
- Registration Number
- RBR-29fy354
- Lead Sponsor
- niversidade Federal de Mato Grosso do Sul
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
Women; aged 18 to 59 years; with a clinical diagnosis of multiple sclerosis according to the Macnonald classification, of the relapsing type; who have symptoms of urinary disorders for at least six months; diagnosed with detrusor overactivity in the urodynamic test; if you cannot get a urodynamic test, the criterion will be at least three of the following symptoms: urgency, urge urinary incontinence, increased urinary frequency, nocturia and nocturnal enuresis
Skin lesions in the area to be treated; cervical, rectal, or genitourinary cancer; if they are pregnant; cardiac pacemaker carriers; presence of urinary tract infection; cognitive decline or illiteracy; presence of genital prolapses; performing abdominal surgeries less than 6 months ago; who already has some history of previous treatment with pelvic floor exercises; who makes previous use of antimuscarinics or other specific medication to control overactive bladder
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the effects of transcutaneous tibial electrical stimulation on urinary symptoms and quality of life in women with Multiple Sclerosis. The Qualiveen - Short Form (Q-FS) and Overactivebladder (OAB-V8) questionnaires will be used as an evaluation method
- Secondary Outcome Measures
Name Time Method The experimental group is expected to have a greater impact on improving symptoms compared to the control group